Steward Partners Investment Advisory’s Stemline Therapeutics, Inc. STML Stock Holding History

Steward Partners Investment Advisory’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,400	Closed	-$21K	–	2820
2020 Q1	$21K	Hold	4,400	–	–	﹤0.01%	1604
2019 Q4	$46K	Hold	4,400	–	–	﹤0.01%	1443
2019 Q3	$45K	Hold	4,400	–	–	﹤0.01%	1404
2019 Q2	$67K	Buy	+4,400	New	+$63.6K	﹤0.01%	1225

Steward Partners Investment Advisory's STML Position: Q2 2020 in Review

Steward Partners Investment Advisory sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 4,400 shares — an estimated $21K sold.

Steward Partners Investment Advisory first reported a position in STML in Q2 2019 and held it in 4 quarters. The position peaked at $67K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Steward Partners Investment Advisory reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 4,400 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $21K.
Steward Partners Investment Advisory first reported a position in Stemline Therapeutics, Inc. in Q2 2019 and held it in 4 quarters.
Steward Partners Investment Advisory's Stemline Therapeutics, Inc. position peaked at $67K in Q2 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.